Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myel
ClinicalTrials.gov study NCT04884191. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01832727. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
ClinicalTrials.gov study NCT01191086. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Open Label Extension Study of AMX0035 in Patients With ALS
ClinicalTrials.gov study NCT03488524. IPD Sharing: NO. Countries: 1. Publications: 3.
A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Mo
ClinicalTrials.gov study NCT01539538. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL
ClinicalTrials.gov study NCT02399085. IPD Sharing: NO. Countries: 10. Publications: 7.
ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection
ClinicalTrials.gov study NCT03183141. IPD Sharing: NO. Countries: 2. Publications: 2.
Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
ClinicalTrials.gov study NCT00413777. IPD Sharing: Not stated. Countries: 1. Publications: 6.
An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
ClinicalTrials.gov study NCT00904826. IPD Sharing: Not stated. Countries: 1. Publications: 8.
A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)
ClinicalTrials.gov study NCT01106391. IPD Sharing: NO. Countries: 1. Publications: 5.
An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
ClinicalTrials.gov study NCT02123966. IPD Sharing: NO. Countries: 1. Publications: 2.
A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatme
ClinicalTrials.gov study NCT02156804. IPD Sharing: Not stated. Countries: 20. Publications: 2.
An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris
ClinicalTrials.gov study NCT02682264. IPD Sharing: NO. Countries: 7. Publications: 0.
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
ClinicalTrials.gov study NCT02431260. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
ClinicalTrials.gov study NCT01202227. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-Label Trial of Tocilizumab in Schizophrenia
ClinicalTrials.gov study NCT01696929. IPD Sharing: NO. Countries: 1. Publications: 16.
Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects
ClinicalTrials.gov study NCT01994109. IPD Sharing: Not stated. Countries: 3. Publications: 3.
An Open Label Study of IgG Fc Glycan Composition in Human Immunity
ClinicalTrials.gov study NCT01967238. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas
ClinicalTrials.gov study NCT05011058. IPD Sharing: NO. Countries: 14. Publications: 2.
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
ClinicalTrials.gov study NCT00438815. IPD Sharing: Not stated. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.